Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of HPV infections
3.2.1.2 Technological advancements in diagnostics
3.2.1.3 Rising awareness and education
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of vaccines and treatments
3.2.2.2 Side effects and safety concerns
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Pipeline analysis
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Disease Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Cervical intraepithelial neoplasia (CIN)
5.3 Cervical cancer
5.4 Anal intraepithelial neoplasia (AIN)
5.5 Anal cancer
5.6 Genital warts
5.7 Other disease types
Chapter 6 Market Estimates and Forecast, By Treatment Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Medication
6.2.1 Vaccines
6.2.2 Anti-viral drugs
6.2.3 Other medications
6.3 Surgery
6.3.1 Cryotherapy
6.3.2 Laser surgery
6.3.3 Other surgery types
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Specialty clinics
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Biocon Ltd.
9.2 Bristol-Myers Squibb Company
9.3 Cleveland Clinic
9.4 Eli Lilly and Company
9.5 F. Hoffmann-La Roche AG
9.6 GlaxoSmithKline plc
9.7 Hologic, Inc.
9.8 INOVIO Pharmaceuticals
9.9 Johnson & Johnson Services Inc. (Janssen Pharmaceutical)
9.10 Mayo Foundation for Medical Education and Research (MFMER).
9.11 Memorial Sloan Kettering Cancer Center
9.12 Merck & Co., Inc.
9.13 Pfizer, Inc.
9.14 The Johns Hopkins Hospital
9.15 Thermo Fisher Scientific Inc.
